OraQuick HCV Rapid Antibody Test approved

The FDA has approved the OraQuick HCV Rapid Antibody Test (from OraSure) to test individuals who are at risk for infection with hepatitis C virus (HCV) and people with signs or symptoms of hepatitis. OraQuick HCV is a test strip and does not require an instrument for diagnosis. Results can be obtained within 20 minutes. OraQuick HCV may be used in patients ≥15 years of age.

For more information www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm217318.htm.